首页> 美国卫生研究院文献>Journal of Korean Medical Science >Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats.
【2h】

Expression and localization of the transforming growth factor-beta type I receptor and Smads in preneoplastic lesions during chemical hepatocarcinogenesis in rats.

机译:大鼠化学性肝癌发生过程中肿瘤前病变中转化生长因子-βI型受体和Smads的表达和定位。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Little is known about the involvement of Smad-related molecules in the regulation of the Transforming Growth Factor (TGF)-beta signaling pathway during hepatocarcinogenesis, particularly with respect to preneoplastic lesions of a rat liver. The aims of this study were to investigate the localizations and temporal expressions of TGF-beta Receptor Type 1 (TGR1) and Smads during the promotion stage of chemical hepatocarcinogenesis in rats. We investigated expressions and localizations of TGR1, Smad2, Smad4, and Smad7 by using semi-quantitative RT-PCR and immunohistochemistry in preneoplastic lesions during rat chemical hepatocarcinogenesis induced by Solt and Farber's method. The down-regulation of TGR1, Smad2, and Smad4 was evident during the later steps of the promotion stage of chemical hepatocarcinogenesis. In contrast with other Smads, increased Smad7 expression was evident during the later steps of the promotion stage. Also immunohistochemistry revealed that the main site of TGR1, Smad2, Smad4, and Smad7 expression was mainly in hepatocytes of the preneoplastic lesions of a rat liver. Dysregulation of the downstream effectors of TGF-beta such as TGR1, Smad2, Smad4 and, Smad7 might contribute to the progression of preneoplastic lesions during chemical hepatocarcinogenesis in a rat.
机译:关于Smad相关分子参与肝癌形成过程中的转化生长因子(TGF)-β信号传导途径的调控知之甚少,特别是对于大鼠肝脏的肿瘤前病变。这项研究的目的是调查在大鼠化学性肝癌发生过程中TGF-β1型受体(TGR1)和Smads的定位和时间表达。我们使用半定量RT-PCR和免疫组化技术研究了由Solt和Farber方法诱导的大鼠化学肝癌形成过程中肿瘤前病变中TGR1,Smad2,Smad4和Smad7的表达和定位。在化学肝癌发生促进阶段的后期,TGR1,Smad2和Smad4的下调很明显。与其他Smads相比,在升级阶段的后期,Smad7表达明显增加。免疫组织化学还显示,TGR1,Smad2,Smad4和Smad7表达的主要位点主要在大鼠肝脏肿瘤形成前病变的肝细胞中。 TGF-β的下游效应子如TGR1,Smad2,Smad4和Smad7的失调可能有助于大鼠化学性肝癌发生期间肿瘤前病变的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号